Stockscreener 앱 받기
6.55
4.97%
0.31
시간 외 거래:
6.23
-0.32
-4.89%
전일 마감가:
$6.24
열려 있는:
$6.22
하루 거래량:
312.44K
Relative Volume:
0.57
시가총액:
$290.84M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-2.82%
1개월 성능:
+18.02%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$6.22
$6.625
1주일 범위
$6.11
$6.89
52주 변동 폭
$4.17
$28.99
Septerna Inc Stock (SEPN) Company Profile
SEPN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SEPN
Septerna Inc
|
6.55 | 290.84M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
512.52 | 131.61B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.36 | 73.51B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
619.97 | 37.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
253.44 | 32.81B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
266.26 | 28.62B | 3.81B | -644.79M | -669.77M | -6.24 |
Septerna Inc Stock (SEPN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-18 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-11-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-11-19 | 개시 | JP Morgan | Overweight |
| 2024-11-19 | 개시 | TD Cowen | Buy |
| 2024-11-19 | 개시 | Wells Fargo | Overweight |
Septerna Inc 주식(SEPN)의 최신 뉴스
SEPN Investors Have Opportunity to Join Septerna, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Septerna, Inc.SEPN - PR Newswire
Septerna, Inc. (SEPN): Among Top Insider Purchases Last Month - Insider Monkey
Top 10 Insider Purchases Last Month - Insider Monkey
Director Makes Bold Move with Major Stock Purchase in Septerna, Inc. - TipRanks
Septerna director Alan Ezekowitz buys $515,934 in common stock By Investing.com - Investing.com Canada
Septerna director Alan Ezekowitz buys $515,934 in common stock - Investing.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Septerna, Inc. (SEPN) And Encourages Shareholders to Reach Out - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Septerna, Inc. (SEPN) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Septerna, Inc. (SEPN): Among The Stocks With At Least $30 Million In Insider Spending Recently - Insider Monkey
10 Stocks With At Least $30 Million In Insider Spending Recently - Insider Monkey
Septerna, Inc. (SEPN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider
Septerna, Inc. Shifts Focus to Next-Gen PTH1R Agonist - TipRanks
Bronstein, Gewirtz & Grossman, LLC Encourages Septerna, Inc. (SEPN) Shareholders to Inquire about Securities Investigation - Markets Insider
Septerna, Inc. (SEPN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Is Investigating Septerna, Inc. (SEPN) And Encourages Investors to Connect - Markets Insider
Top Executives at Septerna, Inc. Make Bold Stock Purchases! - TipRanks
Septerna CEO Jeffrey Finer acquires $96,960 in stock By Investing.com - Investing.com Australia
Septerna CEO Jeffrey Finer acquires $96,960 in stock - Investing.com India
Septerna CFO Labrucherie buys $56,866 in common stock By Investing.com - Investing.com South Africa
Septerna CFO Labrucherie buys $56,866 in common stock - Investing.com India
Bronstein, Gewirtz & Grossman, LLC Encourages Septerna, Inc. (SEPN) Stockholders to Inquire about Securities Investigation - Markets Insider
Major Investment Alert: Third Rock Ventures Boosts Stake in Septerna, Inc. - TipRanks
Third Rock Ventures purchases $113,147 in Septerna stock - Investing.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Septerna, Inc. (SEPN) and Encourages Investors to Learn More About the Investigation - Markets Insider
Septerna to Present at TD Cowen 45th Annual Health Care Conference - The Manila Times
Can Septerna's Revolutionary GPCR Platform Disrupt Drug Discovery? CEO Presents Next Week - StockTitan
Third Rock Ventures acquires $6.17 million in Septerna shares By Investing.com - Investing.com Australia
Major Investment Alert: Septerna, Inc. Gains a Boost from Third Rock Ventures! - TipRanks
Septerna, Inc. (SEPN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Third Rock Ventures acquires $6.17 million in Septerna shares - Investing.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Septerna, Inc. (SEPN) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
Cantor Fitzgerald Expects Higher Earnings for Septerna - Defense World
Septerna CFO Gil Labrucherie acquires $172,296 in common stock By Investing.com - Investing.com Australia
SEPTERNA ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Septerna CFO Gil Labrucherie acquires $172,296 in common stock - Investing.com
Bronstein, Gewirtz & Grossman, LLC Encourages Septerna, Inc. (SEPN) Investors to Inquire about Securities Investigation - Markets Insider
Septerna plunges as safety concerns force an end to early-stage trial - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Septerna, Inc. (SEPN) And Encourages Investors to Reach Out - Markets Insider
Kirby McInerney LLP Announces Investigation Against Septerna, Inc. (SEPN) on Behalf of Investors - GlobeNewswire
Septerna Inc (SEPN) 재무 분석
Septerna Inc (SEPN)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
2.53%
자본화:
|
볼륨(24시간):